Michael Nedelcovych
Stock Analyst at TD Cowen
(0.97)
# 3,680
Out of 4,407 analysts
87
Total ratings
45.3%
Success rate
-2.3%
Average return
Main Sectors:
Stocks Rated by Michael Nedelcovych
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TAK Takeda Pharmaceutical Company | Maintained: Buy | $21 | $15.91 | +31.99% | 14 | Jun 4, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $227 → $250 | $240.87 | +3.79% | 3 | May 29, 2026 | |
| CHRS Coherus Oncology | Maintained: Buy | n/a | $1.40 | - | 13 | May 28, 2026 | |
| RPRX Royalty Pharma | Maintained: Buy | $55 → $50 | $54.87 | -8.88% | 9 | May 6, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $9.80 | $7.09 | +38.17% | 9 | Apr 30, 2026 | |
| SWX: MOLN Molecular Partners AG | Maintained: Buy | CHF 15.00 | $3.03 | +395.05% | 6 | Mar 16, 2026 | |
| NVO Novo Nordisk | Downgraded: Hold | $70 → $42 | $43.88 | -4.28% | 30 | Mar 9, 2026 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Maintained: Buy | ¥5,135 | $5,102.00 | n/a | 1 | May 21, 2025 | |
| MOLN Molecular Partners AG | Maintained: Buy | $17 | $4.11 | n/a | 1 | Mar 14, 2025 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Maintained: Buy | ¥6,550 | $2,550.00 | n/a | 1 | Sep 9, 2024 |
Takeda Pharmaceutical Company
Jun 4, 2026
Maintained: Buy
Price Target: $21
Current: $15.91
Upside: +31.99%
Johnson & Johnson
May 29, 2026
Maintained: Buy
Price Target: $227 → $250
Current: $240.87
Upside: +3.79%
Coherus Oncology
May 28, 2026
Maintained: Buy
Price Target: n/a
Current: $1.40
Upside: -
Royalty Pharma
May 6, 2026
Maintained: Buy
Price Target: $55 → $50
Current: $54.87
Upside: -8.88%
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: $9.80
Current: $7.09
Upside: +38.17%
Molecular Partners AG
Mar 16, 2026
Maintained: Buy
Price Target: CHF 15.00
Current: $3.03
Upside: +395.05%
Novo Nordisk
Mar 9, 2026
Downgraded: Hold
Price Target: $70 → $42
Current: $43.88
Upside: -4.28%
Takeda Pharmaceutical Company Limited
May 21, 2025
Maintained: Buy
Price Target: ¥5,135
Current: $5,102.00
Upside: n/a
Molecular Partners AG
Mar 14, 2025
Maintained: Buy
Price Target: $17
Current: $4.11
Upside: n/a
Daiichi Sankyo Company, Limited
Sep 9, 2024
Maintained: Buy
Price Target: ¥6,550
Current: $2,550.00
Upside: n/a